简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-01-08 17:57 ZOLL Propaq M Selected by U.S. Air Force and U.S. Army as Their Deployable Vital Signs Monitor
2018-01-08 14:38 New Report Provides Snapshot into the Global State of Health Insurance
2018-01-08 14:35 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
2018-01-08 09:32 Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery
2018-01-05 16:47 Carnoustie Takes Wellness and Alternative Medicine To China
2018-01-04 15:56 HeartSciences, a Fierce Innovation Award Finalist, Will Present at BioTech Showcase Events in San Francisco on January 9 and 10, 2018
2018-01-04 10:07 Dr. Xiaoxiang Chen Joins Harbour BioMed as Executive Vice President, Head of Clinical Development and Regulatory Science
2018-01-04 10:04 Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€
2018-01-03 14:26 Masimo Announces CE Marking and Release of Oxygen Reserve Index™ rainbow Lite Sensors
2018-01-02 18:37 RF IDeas Appoints Nicholas Low as Regional Sales Director for Asia Pacific Region
2017-12-25 18:49 Starr Companies Announces Cooperation with PICC Health to Provide Insurance to Chinese Company Employees Working in the Belt & Road Initiative Countries
2017-12-25 10:03 Clover Biopharmaceuticals Receives CFDA Approval to Initiate Clinical Trials in China with Etanercept Biosimilar Candidate SCB-808
2017-12-22 13:24 Denis DELVAL is Appointed CEO of LFB SA
2017-12-21 14:16 LMD Welcomes ‘Smartphone-as-Medical-Instrument’ Trend and Highlights Need for Clinical Accuracy
2017-12-20 15:16 ABEC Expands Vessel Supply and Service Capability for Global Biopharmaceutical Manufacturers
2017-12-15 15:22 BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
2017-12-15 09:33 Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
2017-12-13 10:06 Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program
2017-12-12 15:58 Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
2017-12-12 09:59 Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

Business Wire Weibo

Press Releases

Latest Releases